Shilpa Medicare Ltd. NSE: SHILPAMED | BSE: 530549

Mid-range Performer

Download real time

792.70 -19.60 (-2.41%)

42.83% Gain from 52W Low

250.4K

NSE+BSE Volume

High volume today

NSE 25 Sep, 2025 3:31 PM (IST)

Drug Approval

Shilpa Medicare gets EMA nod for Rivaroxaban, targeting the European market valued at $2.5 billion See details

Shilpa Medicare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shilpa Medicare Ltd. on BSE

Load latest

Is Shilpa Medicare Ltd. worth buying?

248 Votes:

Buy 79.03%

Sell 11.69%

Hold 9.27%